Genetic association with type 1 diabetes (T1D) has been established for two chromosomal regions: HLA DQ/DR (IDDM1) and INS VNTR (IDDM2). To identify additional genetic markers, we tested polymorphisms in regulatory regions of several cytokine and important metabolic genes. These polymorphisms exhibit functional consequences for expression and function. Functional genetic polymorphisms of proinflammatory (T-helper-1: IL-2, IL-12 and IFN-g), anti-inflammatory (T-helper-2: IL-4, IL-6 and IL-10) and metabolic (IGF-I, VDR and INS) genes were determined in 206 Dutch simplex families with juvenile onset T1D and the results were analysed using the transmission disequilibrium test. Significantly increased transmission to T1D probands was observed for the loci IDDM1, IDDM2 and the vitamin D receptor. Although none of the other individual polymorphisms was associated with disease individually, the combination of T-helper-2 and metabolic/growth alleles IL-10*R2, IL-4*C, VDR*C and IGF-I*wt was found to be transmitted more frequently than expected (67%, P c ¼0.015). We conclude that additional genetic predisposition to T1D is defined by combinations of markers (eg Th2 and metabolic) rather than by a single marker. The consequences of the increased transmission of a low Th2 expressing genotypes together with a normal Th1 profile may result in a net proinflammatory cytokine expression pattern.
Introduction
Type 1 diabetes (T1D) is a multifactorial autoimmune disease characterized by the destruction of b-cells, with both environmental and genetic factors contributing to the development of the disease. Extensive research has yielded two genetic risk factors: IDDM1 (HLA-DRB1, -DQB1, -DQA1) and IDDM2 (insulin variable number of tandem repeats, INS VNTR). 1 The contribution to the genetic predisposition is approximately 42% for IDDM1 and 8% for IDDM2, together comprising B50% of the genetic susceptibility to develop T1D. To identify the other 50% of genetic predisposition, several wholegenome scans were performed to identify regions with evidence of linkage to T1D. Apart from a strong reconfirmation of the association between IDDM1 and IDDM2 and T1D, these studies generated various candidate T1D loci. Up to 16 other loci have been identified by linkage studies using affected sib-pair families, but small sample size and ethnic diversity have made the reproduction of these findings in other patient populations difficult. 2, 3 Since b-cell destruction may result from an interaction of many if not all of the products from genes involved in the pathogenesis of T1D, it is conceivable that these candidate genes interact. We applied the so-called multiple hit analysis to identify novel genetic susceptibility factors. This multiple hit theory states that a single locus harbours an undetectably small contribution to the relative risk and only when combinations of genes (synergistically involved in the same regulatory pathways) are analysed together, the relative risk may increase to detectable levels.
We first defined three independent sets of candidate genes that may be involved in the pathogenesis of T1D. Genes were selected on the presence of functional polymorphisms ( Table 1) .
The first set includes genes promoting inflammation: interleukin-2 (IL-2), IL-12 and Interferon-gamma (IFN-g). The second set includes anti-inflammatory genes: IL-4, IL-6 and IL-10. The third set includes genes that contribute to growth, metabolism and beta-cell function: vitamin D receptor (VDR), insulin-like growth factor 1 (IGF-I) and Insulin (INS).
Naïve T cells become activated by an (auto)antigen and start to produce IL-2. This results in a clonal expansion of these T-helper-1 (Th1) cells and induces the production of other proinflammatory cytokines, such as IFN-g, TNFa and TNFb, eventually resulting in the destruction of the pancreatic b-cells. These Th1 cytokines are involved in the activation of the cellular immune response.
The humoral immune response (antibody production by B lymphocytes) is particularly stimulated by T-helper-2 (Th2) cytokines, IL-4 and IL-10 being most predominant. The responses of Th1 and Th2 are mutually inhibitory, 13 although there are some reports that Th2 cytokines actually might accelerate autoimmune destruction. 14 The cytokines involved in the autoimmune -cell annihilation are both regulators and mediators of immune responses, which make them attractive targets for genetic analyses in combination with T1D.
Since b-cells are the target for the autoimmune reaction and development of T1D is associated with birth weight and growth, 15 genes involved in thymic expression of bcell antigens or b-cell development and metabolism were selected as a third group of markers. The INSÀ23 Hph I SNP allele T is reported to be in linkage disequilibrium with the INS VNTR class III alleles while INSÀ23 Hph I allele A is in linkage disequilibrium with the INS VNTR class I alleles. 12 The INS VNTR class III alleles are associated with lower pancreatic insulin mRNA levels, but also with a 2-to 3-fold higher insulin mRNA levels in the thymus, thereby possibly facilitating immune tolerance induction by higher INS expression. 16 Also the VNTR class III alleles are associated with lower birth weight, 17 while high birth weight is a risk factor for T1D. 15, 18 The absence of the IGF-I microsatellite wild type allele is associated with lower birth weight. 19 The IGF receptor-1 and insulin receptor can form functional heterodimer receptors. 20 We therefore hypothesize that the IGF-I microsatellite may be a marker for T1D susceptibility. Furthermore, IGF-1 was reported to have proliferative effects on T lymphocytes, 21 suggesting that high-level IGF-1 individuals have increased T-cell proliferation. Vitamin D is known as a factor that regulates calcium and bone metabolism. 22 Besides this role, the active form of vitamin D (1a,25-dihydroxyvitamin D3) has been reported as a factor that redirects differentiation and maturation of dendritic cells, 23 inhibits T-cell proliferation, 23 suppresses both TNFa and IL-1 production and affects MHC class II expression. 24 Recently, an association between the VDR FokI polymorphism and the insulin secretory capacity was reported. 22 We hypothesize that a genotype made up from multiple markers from our list of candidate genes will be significantly associated with the disease. Such a genotype may consist of markers from the inflammatory cluster, the anti-inflammatory cluster, the metabolic cluster or a combination of these.
Results
Loci were first analysed separately, which resulted as expected in a significant association with the disease for HLA-DQ and HLA-DR (P¼3.8 Â 10 À28 and 9.9 Â 10 À29 respectively, 1.0 Â 10 À33 combined) and for INS-23 Hph I (P¼0.0004) but also with VDR-Fok I (P¼0.011). None of the other loci showed significant association on an individual basis, although the IL-4 polymorphism showed a hint of association (P¼0.058, Table 2 ). We then analysed the combined loci within the predefined groups (proinflammatory genes, anti-inflammatory genes and metabolic genes) using multiallelic extended transmission disequilibrium test (ETDT). While Th1 markers were not associated with T1D, significantly increased transmission of the metabolic markers was observed (P c ¼0.027 after correction for testing three groups). In particular, the allelic combination ''IGF-I*wt VDR*C'' showed increased transmission (T¼62.2%, P¼0.001, P c ¼0.027). Addition of the INS locus to the IGF-I-VDR combination resulted in a slightly increased transmission of the ''IGF-I*wt VDR*C INS*A'' combination (T¼63.9%, P¼0.0001). The complete anti-inflammatory Th2 group showed no association. However, the IL-4, IL-10 combination showed a trend of association, which was not significant after correction for the number of tests (P¼0.01). Furthermore, increased transmission of the Th2 allelic combination ''IL-4*C, IL-10*R2'' (T¼61.9%, P¼0.003, P c ¼NS) was observed .
Combining the Th2 markers with the metabolic markers showed association with T1D by multiallelic ETDT (P¼0.00001). After correction for the number of testable allelic combinations and the number of combinations of four loci, the IL-10*R2, IL-4*C, VDR*C, IGF-I*wt, transmission remained significant (P c ¼0.00001 Â 12 Â 126¼0.015).
To test whether these associations contribute to the risk for T1D in addition to the risk confered by HLA and INS, the transmission of the allelic combination IL-10*R2, IL-4*C, VDR*C, IGF-I*wt (¼''X'') in combination with IDDM1 and 2 was analysed. The conditional extended transmission disequilibrium test (CETDT) showed that Genetic polymorphisms in type 1 diabetes P Eerligh et al the susceptibility of X added to that of IDDM2 (P¼0.015).
INS -23
Hph I is a diallelic locus with a transmission rate of 34% for allele T and 66% for allele A. The cotransmission of the allelic combination X increases the transmission rate of both INS alleles by 16% compared to when the allelic combination X was absent (Table 3) . A similar analysis was performed to study the effect of the allelic combination X in addition to the susceptibility of IDDM1. Again the CETDT showed an additional effect of combination X on top of IDDM1 (P¼0.0038). Additionally, the allelic combination X was again responsible for transmission alteration. The strongest effect could be demonstrated on HLA-DR3/DQ2 (Figure 1 ): transmission of DQ/DR without any of the loci IL-10, IL-4, VDR or IGF (¼X0) was 68.8%. The co-transmission of the allelic combination X (¼X þ ) increases the transmission rate of DR3/DQ2 by 20-88.9 (P¼0.033), while all other allelic combinations of the loci IL-10, IL-4, VDR and IGF grouped together (XÀ) decreased transmission of DR3/ DQ2 by 10-58.5% (P¼0.13). Interestingly, the effect of the allelic combination X on DR4DQ8 seems negligible (X0¼86.5%, X þ ¼87.5% (P¼0.89) and X À ¼82.1% (P¼0.35)). Analyses of the odds ratios (OR, Table 4) of the different haplotype combinations showed that the OR of DR4DQ8X þ increased by a factor of 1.26 compared to that of DR4DQ8XÀ. For DR3DQ2X þ , however, the increase was by a factor of 4.46. These data suggest that DR3-DQ2 is a cytokine/metabolic ''sensitive'' haplotype while DR4DQ8 seems unaffected.
Discussion
In this study, we found only a single independent additional genetic effect for T1D for the vitamin D receptor, although some markers showed a trend of association (IL-4, IGF-I). However, when the markers were clustered and analysed in predefined groups with reference to specific functions, we found that the Th1 cluster (IFN-g, IL-2 and IL-12) showed an The co-transmission of allelic combination X increases the transmission rate of both INS alleles by 15%. The absence of X results in a neutral transmission rate for INS*A, and a protective transmission rate (35%) for INS*T. T¼transmitted; NT¼nontransmitted; %T¼percentage transmitted; X+¼IL-10*R2, IL-4*C, VDR*C, IGF-I*wt; XÀ¼all other allelic combinations of the loci IL-10, IL-4, VDR and IGF-I; OR¼odds ratio. Figure 1 Effect of allelic combination X on HLA DQ/DR. The cotransmission of allelic combination X either increases DRDQ transmission (DR3DQ2 and DR13DQ6) or has no effect on DRDQ transmission (DR1DQ5 and DR4DQ8). DR15DQ6X þ represents the allelic combination of DR15DQ6 and IL-10*R2, IL-4*C and VDR*C and IGF-I*wt. DR15DQ6XÀ includes all other combinations of DR15DQ6 with IL-10, IL-4, VDR and IGF.
Genetic polymorphisms in type 1 diabetes P Eerligh et al undisturbed transmission rate of the markers while the Th2 cluster (IL-4, IL-6 and IL-10) showed a preferential transmission of the alleles associated with low IL-4 and normal IL-10 serum levels. The metabolic cluster (IGF-I, INS and VDR) added to the susceptibility in combination with the Th2 cluster. These data suggest that the Th1 disease T1D is not influenced by a genetic predisposition of the Th1 genes tested here, but by a distortion of the Th2 and metabolic gene clusters tested. Owing to the extreme sensitivity of the Th1-Th2 balance, a slight decrease in Th2 cytokines will result in a relative Th1 cytokine overload, possibly resulting in destructive insulitis. To determine if this is really the case in our study group, patient serum cytokine levels should be measured and correlated with their genotypes. Obviously, we can not rule out that untested Th1 markers will have an influence on T1D susceptibility. We were able to confirm the loci IDDM1 and IDDM2 in our study group. As expected, many of our candidate loci were not associated with T1D individually.
With these results, we have also demonstrated the usefulness of the multiple hit approach. Association with the disease was revealed after grouping the markers into Th1, Th2 and metabolic groups in a study population of only 206 families.
To assess whether the genetic contribution to disease susceptibility added to that of IDDM1 and IDDM2, samples were stratified for HLA-DR/-DQ and INS. We demonstrate that the co-transmission of our allelic combination X increased the transmission rate of some DR-DQ haplotypes, indicating that there might be an additive effect of allelic combination X to IDDM1. The differences in OR suggest even a synergistic effect of allelic combination X on DR3DQ2. Interestingly, in the absence of X, the INS-A allele has a 50% transmission rate, whereas INS-T allele showed a reduced transmission of 36%. Hence, this observation suggests that the INS locus only contains a protective allele (HphI T allele), and that the apparent susceptibility of allele A is caused by X. Therefore, these data suggest that the INS À23 HphI locus only contains a protective allele (T), and that the apparent susceptibility of allele A is caused by X.
Our results confirm the established risk markers HLA and insulin-VNTR, and add combinations of novel markers that independently of the established markers contribute to genetic predisposition to T1D. Intriguingly, these new markers might associate with an imbalance of the Th2 cytokine profile in favour of Th1 that predisposes to autoimmune b-cell destruction and accord with the association of birth weight and growth with risk for T1D. Although our study does not confirm several previously reported polymorphisms found to be associated with susceptibility for T1D, it is conceivable that the remaining risk factors for diabetes confer relatively low risk determined in underpowered studies at the border of detection. Through stochastic variation, such studies can show conflicting results.
Material and methods
Subjects. The data set consisted of 206 simplex families of Dutch origin through a single proband with juvenile onset T1D consisting of a patient with both parents. Age of onset of patients was younger than 14 years with an average of 4 years.
Loci. See Table 1 .
Genotyping. Amplification of all loci was performed in a total volume of 11 ml, containing B10 ng genomic DNA, 200 mM dNTPs, 5% glycerol, 50 mM KCl, 10 mM Tris (pH 8.4) 1.5 mM MgCl 2 , 0.06 mg/ml BSA and 0.2 U of Taq polymerase. RFLP was applied on the loci IL-4, IL-12 and the INS VNTR. Amplification products were digested using 1 U of the restriction enzymes BsmFI, aTaqI or HphI respectively. ARMS PCR was used for IL-2 and IL-6. Both RFLP and ARMS products were separated on a 4% ethidium bromide stained agarose gel and alleles were called using a 25 bp ladder as reference. The CA repeat microsatellite polymorphisms in the IL-10, IFN-g and IGF-I genes were amplificated using a 5 0 Cy-5 labelled forward primer. Products were separated on an 8% polyacrylamide gel using an ALF Express and analysed using Fragment Analyser 1.01 (Amersham Pharmacia Biotech). The designations and sequences of the primers used are available on request.
Statistical analyses. Transmission disequilibrium test (TDT) and CETDT were performed using the TDTPHASE program. 29 The correction of single marker P-values was 11 (HLA-DQ and -DR, INS and the eight unestablished loci). Since we were interested in combination of loci in similar pathways, loci within one group were tested by multiallelic ETDT and corrected for testing three groups. Correction of the P-values for specific allelic combinations within a group was by the number of observed and testable allelic combinations (showing more than 10 counts). The combination of Th2 and metabolic markers was corrected for the number of observed and testable allelic combinations and the number of combinations of four markers possible (12 and 126, respectively, total correction factor 1512). Corrected P-values are indicated as ''P c ''. Genetic polymorphisms in type 1 diabetes P Eerligh et al
